The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1803 participants.
Also called NCT04437654
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,803 participants
- Sponsor
- Registry
-
NCT04437654
-
- Other papers using this trial's data
- Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04437654. Randomized; no masking; primary purpose treatment. Start 2020-07-28 (actual); primary completion 2025-08-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
- Condition
- Atrial Fibrillation Patients With Intermediate Stroke Risk
- Intervention (Drug)
- Anticoagulation group(DOAC group)
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct04437654- Content hash
8d7ca11bc6fb1a3abf39361317d6a08abe77171ba4e2594b58c1b22c3ca64557